Institutional Biosafety Committee
The purpose of the Georgetown University Institutional Biosafety Committee (IBC) is to provide regulatory guidance to research personnel to ensure the safe conduct of biomedical research projects, while maintaining compliance with local, state, and federal requirements. Protocol approvals are required for research involving the use of infectious microorganisms, recombinant DNA, and biological toxins. The IBC carries out these functions pursuant to requirements set forth by the National Institutes of Health, and NIH Guidelines For Research Involving Recombinant DNA Molecules. EH&S performs risk assessments in order to develop biosafety policies and procedures and to set containment levels that ensure the safety of Georgetown University employees and the surrounding community. The IBC serves to provide protocol review and approval, as well as, for amended protocols. A formal letter is issued to the Principal Investigator, and other regulatory stakeholders, to document that the research project has been approved by the committee.
IBC Meetings
IBC meetings will be held on the third Friday of every month. Meetings will be canceled if there are no new protocols, renewals or amendments submitted by the due date of each month.
Note: Meeting dates are subject to committee member availability. Please see IBC meeting schedule for official and tentative dates.
IBC Meeting Schedule 2023
Month | Protocols Due | Meeting Date |
---|---|---|
January | 1/6/2023 | 1/20/2023 |
February | 2/3/2023 | 2/17/2023 |
March | 3/3/2023 | 3/17/2023 |
April | 4/7/2023 | 4/21/2023 |
May | 5/5/2023 | 5/19/2023 |
June | 6/2/2023 | 6/16/2023 |
July | 7/7/2023 | 7/21/2023 |
August | 8/4/2023 | 8/18/2023 |
September | 9/1/2023 | 9/15/2023 |
October | 10/6/2023 | 10/20/2023 |
November | 11/3/2023 | 11/17/2023 |
December | 12/1/2023 | 12/15/2023 |
Protocols that are not submitted on the due date, will be reviewed at the next scheduled meeting. The IBC will not review any submission that is not complete and has not addressed edits or clarifications requested by EH&S. These protocols will also be postponed for review to the next month.
Membership Roster 2022-2023
Vicente Notario, Ph.D. (Chair) Professor, Radiation Medicine E 208, Research BLDG (202) 687-2102 notariov@georgetown.edu | John Casey, Ph.D (Vice-Chair) Associate Professor, Microbiology & Immunology NE 323, Med-Dent (202) 687-1052 caseyj@georgetown.edu |
Seema Agarwal, Ph.D. Associate Professor, Pathology, GCD 7A, Preclinical Science (202) 687-2644 sa1137@georgetown.edu | Marta Catalfamo, Ph.D. Associate Professor, Microbiology & Immunology EG 12, Research BLDG (202) 687-8675 mc2151@georgetown.edu |
Danelle Chavez, MPH Interim EH&S Leader, EH&S, LM 12 Preclinical Science, 202-687-4712 dc1237@georgetown.edu | Julie Fischer, Ph.D. Adjunct Faculty, Microbiology & Immunology 202-471-0591 jef100@georgetown.edu |
Crystal Johnson, DVM Professor, School of Medicine G 05 RRF Preclinical Science (202) 687-0242 cj588@georgetown.edu | Kathleen Pirollo, Ph.D. Professor, Experimental Therapeutics E 416, Research BLDG (202) 687-8418 pirollok@georgetown.edu |
Ms. Susan Commins Gallagher (Community Member) 4018 Mansion Drive, Washington, DC 20007 (202) 365-2398 (H) Susangallagher4298@gmail.com | Ms. Zelda R. McDonald (Community Member) 19636 Olney Mill Rd. Brookeville, MD 20833 (301) 570-4865 (H) zeldamcd@verizon.net |
Rodney Freeman, (Administrative Officer / IBC Contact Person) LM 12, Preclinical Science (202) 687-2566 freemanr@georgetown.edu |